Literature DB >> 27020908

Concurrent and prospective associations of intolerance of uncertainty with symptoms of prolonged grief, posttraumatic stress, and depression after bereavement.

Paul A Boelen1, Albert Reijntjes2, Geert E Smid3.   

Abstract

This study examined associations of Prospective IU and Inhibitory IU with symptom-levels of Prolonged Grief Disorder (PGD), Posttraumatic Stress-Disorder (PTSD), and depression in a sample of bereaved individuals. Specifically, 265 bereaved individuals completed measures of IU, PGD, PTSD, and depression in the first year after the death of a loved one; 134 participants again completed symptom-measures six months later. Cross-sectional analyses showed that Inhibitory IU (but not Prospective IU) was positively associated with symptom-levels of PTSD and depression (but not PGD), even when controlling for neuroticism, worry, and rumination. Prospective analyses showed that Prospective IU (but not Inhibitory IU) at baseline, predicted PGD severity six months later (but not PTSD or depression at follow-up) while controlling for baseline symptom-levels. The findings support the notion that IU is a vulnerability factor for different emotional problems, including those developing after the death of a loved one. Clinical implications of these findings are discussed.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bereavement; Depression; Intolerance of uncertainty; Posttraumatic stress; Prolonged grief

Mesh:

Year:  2016        PMID: 27020908     DOI: 10.1016/j.janxdis.2016.03.004

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  10 in total

1.  Shifting and intersecting needs: Parents' experiences during and following the withdrawal of life sustaining treatments in the paediatric intensive care unit.

Authors:  Elizabeth G Broden; Allison Werner-Lin; Martha A Q Curley; Pamela S Hinds
Journal:  Intensive Crit Care Nurs       Date:  2022-02-24       Impact factor: 4.235

2.  Enhancing Inhibitory Learning: The Utility of Variability in Exposure.

Authors:  Kelly A Knowles; Bunmi O Olatunji
Journal:  Cogn Behav Pract       Date:  2018-01-31

3.  Conflict-related trauma and bereavement: exploring differential symptom profiles of prolonged grief and posttraumatic stress disorder.

Authors:  Carina Heeke; Nadine Stammel; Manuel Heinrich; Christine Knaevelsrud
Journal:  BMC Psychiatry       Date:  2017-03-29       Impact factor: 3.630

4.  A pilot randomised controlled trial of metacognitive therapy for prolonged grief.

Authors:  Jenine Anne Wenn; Moira O'Connor; Robert T Kane; Clare Samantha Rees; Lauren J Breen
Journal:  BMJ Open       Date:  2019-01-09       Impact factor: 2.692

5.  Factorial validity and measurement invariance of the uncertainty response scale.

Authors:  Mariana Lucas Casanova; Lara S Pacheco; Patrício Costa; Rebecca Lawthom; Joaquim L Coimbra
Journal:  Psicol Reflex Crit       Date:  2019-12-18

6.  Prolonged grief and posttraumatic stress disorder following the loss of a significant other: An investigation of cognitive and behavioural differences.

Authors:  Kirsten V Smith; Anke Ehlers
Journal:  PLoS One       Date:  2021-04-01       Impact factor: 3.240

7.  Demographic and cognitive risk factors for police mental disorder symptoms.

Authors:  Stephanie Korol; Kelsey D Vig; Michelle J N Teale Sapach; Gordon J G Asmundson; R Nicholas Carleton
Journal:  Police J       Date:  2019-12-17

8.  The impact of psychological hardiness on intolerance of uncertainty in university students during the COVID-19 pandemic.

Authors:  Meltem Oral; Nurgül Karakurt
Journal:  J Community Psychol       Date:  2022-04-12

9.  Hyperreactivity to uncertainty is a key feature of subjective cognitive impairment.

Authors:  Bahaaeddin Attaallah; Pierre Petitet; Elista Slavkova; Vicky Turner; Youssuf Saleh; Sanjay G Manohar; Masud Husain
Journal:  Elife       Date:  2022-05-10       Impact factor: 8.713

10.  A framework of meaning attribution following loss.

Authors:  Geert E Smid
Journal:  Eur J Psychotraumatol       Date:  2020-10-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.